Trials / Completed
CompletedNCT01914666
An Open Label Extension Study of Duloxetine (LY248686) in Participants With Chronic Low Back Pain
Phase 3 Clinical Study of Duloxetine Hydrochloride in Patients With CLBP - Open Label Long Term Extension Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 151 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 20 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to assess the long term safety of duloxetine in participants with Chronic Low Back Pain (CLBP).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Duloxetine | Administered orally |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2013-08-02
- Last updated
- 2016-01-27
- Results posted
- 2016-01-27
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01914666. Inclusion in this directory is not an endorsement.